Article Information
History
- November 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Christian Kirkup1,+,
- Colin Pawlowski1,+,
- Arjun Puranik1,
- Ian Conrad1,
- John C. O’Horo2,
- Dina Gomaa3,
- Valerie M. Banner-Goodspeed4,
- Jarrod M Mosier5,
- Igor Borisovich Zabolotskikh6,
- Steven K. Daugherty7,
- Michael A. Bernstein8,
- Howard A. Zaren9,
- Vikas Bansal2,
- Brian Pickering2,
- Andrew D. Badley2,
- Rahul Kashyap2,
- AJ Venkatakrishnan1,* and
- Venky Soundararajan1,*
- 1nference, One Main Street, Suite 400, East Arcade, Cambridge, MA 02142, USA
- 2Mayo Clinic, Rochester MN, USA
- 3University of Cincinnati, Cincinnati, OH, USA
- 4Beth Israel Deaconess Medical Center, Boston, MA, USA
- 5Banner University Medical Center, Tucson, AZ, USA
- 6Kuban State Medical University, Krasnodar, Russia
- 7Cox Medical Center Springfield, IL, USA
- 8Stamford Health, Stamford, CT, USA
- 9St. Joseph’s Candler Health System, Savannah, GA, USA
- ↵*Correspondence to: Venky Soundararajan (venky{at}nference.net) or AJ Venkatakrishnan (aj{at}nference.net)
Posted November 10, 2020.
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry
